Skip to content

The effects of peptide on lowering blood pressure: a randomized, double blind, placebo-controlled study.

The effects of peptide on lowering blood pressure: a randomized, double blind, placebo-controlled study. - The effects of peptide on lowering blood pressure: a randomized, double blind, placebo-controlled study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052102
Enrollment
200
Registered
2023-09-04
Start date
2023-09-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Sponsors

Matsumoto City Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Subjects aged 20-74 years 2)Subjects with systolic blood pressure less than 140 mmHg and diastolic blood pressure less than 90 mmHg 3)Subjects with systolic blood pressure more than 120 mmHg or diastolic blood pressure more than 80 mmHg

Exclusion criteria

Exclusion criteria: 1) Subjects who are undergoing continuous medical treatment. 2) Subjects who regularly use food for specified health uses, functional foods, health foods whose affects this study. 3) Subjects who smoke 20 cigarettes or more per day. 4) Subjects drink alcohol polydipsia (pure alcohol equivalent more than 60 g/day) 5) Subjects whose BMIs are >=30 kg/m^2. 6) Subjects who are under treatment or have a history of disorders such as the heart, liver, kidney, digestive organs, etc. 7) Subjects who have serious allergies to medicines and foods 8) Subjects who are pregnant, planning to become pregnant, or lactating. 9) Subjects who participated in clinical trials of other drugs or foods within one month, or who plan to do just after giving informed consent. 10) Subjects who are judged inappropriate to this trial by the principal investigator.

Design outcomes

Primary

MeasureTime frame
Systolic blood pressure and diastolic blood pressure

Countries

Japan

Contacts

Public ContactFuruhata Katsuya

Matsumoto Health Lab None

info@m-health-lab.jp0263-39-1139

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026